Guardant Health (GH)
(Delayed Data from NSDQ)
$21.40 USD
+0.79 (3.83%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $21.38 -0.02 (-0.09%) 7:08 PM ET
3-Hold of 5 3
F Value D Growth B Momentum D VGM
Cash flow Statements
Fiscal Year End for Guardant Health, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -479.45 | -654.59 | -384.77 | -246.28 | -67.85 |
Depreciation/Amortization & Depletion | 31.90 | 43.13 | 37.68 | 24.81 | 11.30 |
Net Change from Assets/Liabilities | 53.84 | 61.56 | -40.47 | -47.67 | -6.09 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 68.73 | 240.44 | 178.54 | 165.21 | 15.51 |
Net Cash From Operating Activities | -324.98 | -309.46 | -209.02 | -103.93 | -47.13 |
Property & Equipment | -20.49 | -77.46 | -75.04 | -36.17 | -18.72 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | -7.33 |
Investments | 859.21 | 227.28 | 11.88 | -563.03 | -288.96 |
Other Investing Activities | 1.53 | 0.00 | 0.00 | -17.89 | -2.57 |
Net Cash from Investing Activities | 840.25 | 149.82 | -63.16 | -617.09 | -317.57 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 503.68 | 11.94 | 17.87 | 372.35 | 368.47 |
Issuance (Repayment) of Debt | 0.00 | -0.07 | -0.15 | 1,132.58 | -0.44 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -26.30 | -200.96 | -84.54 | -94.62 | -0.72 |
Net Cash from Financing Activities | 477.38 | -189.09 | -66.82 | 1,410.31 | 367.30 |
Effect of Exchange Rate Changes | -0.91 | -1.60 | -1.69 | 0.46 | 0.08 |
Net Change In Cash & Equivalents | 991.74 | -350.34 | -340.69 | 689.75 | 2.68 |
Cash at Beginning of Period | 141.95 | 492.29 | 832.98 | 143.23 | 140.54 |
Cash at End of Period | 1,133.69 | 141.95 | 492.29 | 832.98 | 143.23 |
Diluted Net EPS | -4.28 | -6.41 | -4.00 | -2.60 | -0.84 |
Fiscal Year End for Guardant Health, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -217.61 | -114.99 | -479.45 | -292.41 |
Depreciation/Amortization & Depletion | NA | 22.73 | 11.47 | 31.90 | 23.03 |
Net Change from Assets/Liabilities | NA | -45.83 | 7.87 | 53.84 | -10.33 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 116.43 | 65.37 | 68.73 | 33.46 |
Net Cash From Operating Activities | NA | -124.29 | -30.28 | -324.98 | -246.25 |
Property & Equipment | NA | -12.01 | -6.93 | -20.49 | -16.41 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 35.00 | 35.00 | 859.21 | 193.21 |
Other Investing Activities | NA | 0.00 | 0.00 | 1.53 | 0.00 |
Net Cash from Investing Activities | NA | 22.99 | 28.07 | 840.25 | 176.80 |
Uses of Funds
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 9.79 | 0.21 | 503.68 | 409.49 |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | -4.97 | -1.29 | -26.30 | -22.68 |
Net Cash from Financing Activities | NA | 4.82 | -1.07 | 477.38 | 386.81 |
Effect of Exchange Rate Changes | NA | -1.98 | -1.14 | -0.91 | -1.94 |
Net Change In Cash & Equivalents | NA | -98.45 | -4.43 | 991.74 | 315.42 |
Cash at Beginning of Period | NA | 1,133.69 | 1,133.69 | 141.95 | 141.95 |
Cash at End of Period | NA | 1,035.24 | 1,129.26 | 1,133.69 | 457.36 |
Diluted Net EPS | NA | -0.84 | -0.94 | -1.58 | -0.73 |